Skip to content

Study · In vitro (cells) · rat · 1997

1 result

Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture.

Barreca AM, Voci A, Lee PD, Arvigo M, Ghigliotti V, Fugassa E, Giordano G, Minuto F

European journal of endocrinology1 Aug 1997Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In primary adult rat hepatocytes, des(1‑3)IGF-I did not affect acid-labile subunit release.

    In plain wordsIn cells from rats, des(1‑3)IGF-I did not change acid-labile subunit release compared with control.

    Outcome
    No significant changeAcid-labile subunit release
    Study

    ratn: not reported in source

    Primary adult rat hepatocytes
    Comparator
    Vehicle control
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    2) the release of ALS by adult rat hepatocytes is not affected by the presence during the incubation of des(1-3)IGF-I or IGF-II;
    1 context sentence
    Summary · context
    The regulation of ALS release was evaluated in the conditioned medium of adult rat hepatocytes exposed to increasing concentrations of test substances or to vehicle alone (control), after gel filtration in basic conditions, by immunoblot using an antiserum generated against the N-terminal 34 amino acids of human ALS.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    27 Oct 2026, 16:36 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    21 Oct 2026, 15:58 UTC

    Study results updated

  3. Version 2

    21 Oct 2026, 13:52 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.